<!DOCTYPE article PUBLIC "-//NLM//DTD Journal Publishing DTD v2.3 20070202//EN" "journalpublishing.dtd">
<article article-type="case-report" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">
<front>
<journal-meta>
<journal-id journal-id-type="publisher-id">OURD</journal-id>
<journal-title>Our Dermatol Online</journal-title>
<issn pub-type="epub">2081-9390</issn>
<publisher>
<publisher-name>Our Dermatology Online</publisher-name>
<publisher-loc>Poland</publisher-loc>
</publisher>
</journal-meta>
<article-meta>
<article-id pub-id-type="publisher-id">OURD-6-325</article-id>
<article-id pub-id-type="doi">10.7241/ourd.20153.86</article-id>
<article-categories>
<subj-group subj-group-type="heading">
<subject>Case Report</subject>
</subj-group>
</article-categories>
<title-group>
<article-title>An interesting uncommon side effect of topical corticosteroids-hidradenitis suppurativa</article-title>
</title-group>
<contrib-group>
<contrib contrib-type="author">
<name>
<surname>Inakanti</surname>
<given-names>Yugandar</given-names>
</name>
<xref ref-type="aff" rid="aff1">1</xref>
<xref ref-type="corresp" rid="cor1"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Rao</surname>
<given-names>Thimmasarthi Venkata Narsimha</given-names>
</name>
<xref ref-type="aff" rid="aff2">2</xref>
</contrib>
</contrib-group>
<aff id="aff1"><label>1</label><italic>Department of Dermatology, Venerology and Leprosy, P.E.S. Medical College, Kuppam, India</italic></aff>
<aff id="aff2"><label>2</label><italic>Department of Dermatology, Venerology and Leprosy, Guntur Medical College, Guntur, India</italic></aff>
<author-notes>
<corresp id="cor1">
<bold>Corresponding author:</bold> Dr. Yugandar Inakanti, E-mail: <email xlink:href="dryugandar@gmail.com">dryugandar@gmail.com</email>
</corresp>
</author-notes>
<pub-date pub-type="ppub">
<year>2015</year>
</pub-date>
<volume>6</volume>
<issue>3</issue>
<fpage>325</fpage>
<lpage>327</lpage>
<history>
<date date-type="received"><day>26</day><month>12</month><year>2014</year></date>
<date date-type="accepted"><day>04</day><month>06</month><year>2015</year></date>
</history>
<permissions>
<copyright-statement>Copyright: &#x000a9; Our Dermatol Online 3</copyright-statement>
<copyright-year>2015</copyright-year>
<license license-type="open-access" xlink:href="http://creativecommons.org/licenses/by-nc-sa/3.0">
<p>This is an open-access article distributed under the terms of the Creative Commons Attribution-Noncommercial-Share Alike 3.0 Unported, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.</p>
</license>
</permissions>
<abstract>
<p>There are many local and systemic side-effects of topical corticosteroids. To the best of our Knowledge, Hidradenitis Supportive (HS) due to topical corticosteroids has not been reported previously. We report a 39-year old, male patient who started himself a topical corticosteroid Pander Plus cream because of itching, scaly lesions over groins and buttocks since 6 months. After 4 months of topical treatment, he developed pus discharging sinuses over both groins and buttocks. Based on patient history, clinical and laboratory findings and the exclusion of other diagnoses, HS points out the use of topical corticosteroids. The case well highlights this unusual condition and represents the first case reported in India to our best of the knowledge. Having performed thorough literature search I would like to discuss in this report the evidence for this relation and stress the importance of appropriate usage of topical corticosteroids.</p>
</abstract>
<kwd-group>
<kwd>Hidradenitis</kwd>
<kwd>pus</kwd>
<kwd>sinus discharge</kwd>
<kwd>skin atrophy</kwd>
<kwd>striae</kwd>
<kwd>topical steroid</kwd>
</kwd-group>
</article-meta>
</front>
<body>
<sec id="sec1-1" sec-type="intro">
<title>INTRODUCTION</title>
<p>Topical corticosteroids have now been in use for treating skin disease for over half a century, since the introduction of compound F or hydrocortisone (cortisol) in 1952 [<xref ref-type="bibr" rid="ref1">1</xref>]. Many local and systemic side effects have become more prevalent since the uncontrolled use of high potency topical corticosteroids. The most common local side effects are atrophy, acneiform eruptions, erythema, folliculitis, hyper pigmentation, hypertrichosis, hypo pigmentation, Purpura, Striae, susceptibility to infections and Telangiectasia [<xref ref-type="bibr" rid="ref2">2</xref>]. Here in, we report a case of HS due to using a topical corticosteroid cream.</p>
</sec>
<sec id="sec1-2" sec-type="cases">
<title>CASE REPORT</title>
<p>A 39 year-old male patient reported to our department with complaints of pus discharging sinuses over both groins and buttocks since 2 months duration, past history of uncontrolled use of topical corticosteroid cream for itching over groins and buttocks for a period of 4 months. It was prescribed by friend initially and he got it over the counter sale. According to his history he did not have any systemic disease. He had only itching scaly skin lesions over groins and buttocks. He used topical corticosteroid cream by himself uncontrollably for improvement of itching without consulting dermatologist. Recently he underwent surgical excision of abscess over buttocks in private hospital. Physical examination was normal. Laboratory investigations revealed leucocytosis raised ESR, normal Liver function tests and Kidney function tests.</p>
<p>On Local examination:</p>
<p>
<list list-type="order">
<list-item>
<p>Longitudinal striae over supra pubic area and flanks, hypopigmentation over both groins (<xref ref-type="fig" rid="F1">Fig. 1</xref>);
<fig id="F1">
<label>Figure 1</label>
<caption>
<p>Multiple striae over anterior abdomen, flanks and thighs. shows multiple discharging sinuses over pubic area, few with crusting.</p>
</caption>
<graphic xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="OURD-6-325-g001.tif"/>
</fig>
</p>
</list-item>
<list-item>
<p>Skin atrophy over both groins and pubic area (<xref ref-type="fig" rid="F2">Fig. 2</xref>);
<fig id="F2">
<label>Figure 2</label>
<caption>
<p>Skin atrophy over both groins and pubic area.</p>
</caption>
<graphic xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="OURD-6-325-g002.tif"/>
</fig>
</p>
</list-item>
<list-item>
<p>Multiple discharging sinuses with healed scars over buttocks and hypertrichosis (<xref ref-type="fig" rid="F3">Fig. 3</xref>);
<fig id="F3">
<label>Figure 3</label>
<caption>
<p>Multiple discharging sinuses over inter gluteal region, scar and hypertrichosis.</p>
</caption>
<graphic xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="OURD-6-325-g003.tif"/>
</fig>
</p>
</list-item>
<list-item>
<p>Circular shaped crusted lesion over the left medial aspect of the thigh and multiple discharging sinuses over left groin with pus (<xref ref-type="fig" rid="F4">Fig. 4</xref>).
<fig id="F4">
<label>Figure 4</label>
<caption>
<p>Multiple discharging sinuses over left groin with pus.</p>
</caption>
<graphic xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="OURD-6-325-g004.tif"/>
</fig>
</p>
</list-item>
</list>
</p>
<p>Based on the patient&#x2019;s history, clinical and laboratory findings and the exclusion of other diagnoses, the HS associated with the use of topical corticosteroids cream was diagnosed. Pus culture and sensitivity was done. In Gram stain of pus culture showed staphylococcus aureus and anaerobic streptococci. It showed Sensitivity to Vancomycin, Tecoplanin and Gatifloxacin.</p>
</sec>
<sec id="sec1-3" sec-type="discussion">
<title>DISCUSSION</title>
<p>Supportive hidradenitis is a chronic relapsing inflammatory disease originating in apocrine gland follicles, which may become chronic and often indolent due to subcutaneous extension with induration, scarring, destruction of skin appendages and sinus formation [<xref ref-type="bibr" rid="ref3">3</xref>].</p>
<p>Comedonal occlusion of the &#x201C;apocrine gland follicle&#x201D; unit therefore obstructs the outflow of the apocrine gland in addition to that of the sebaceous gland, and is believed to be the initiating event in hidradenitis.</p>
<p>Friction and pressure accentuate the inflammatory changes that invade the fat and cause further granulomatous change extending widely over the buttocks and thighs. Persistent perineal sinuses are frequent, and deep lesions cause anal fistulae.</p>
<p>Keratin Plugs are identified in apocrine gland follicles, leukocyte inflammatory cells in ducts of glands. As the apocrine gland extends well below the dermis into the less supportive subcutaneous tissue, the suppuration readily breaks through the gland and extends under the skin.</p>
<p>Laboratory investigations show higher yield of potential pathogens Staphylococcus aureus, anaerobic streptococci and, notably, the microaerophilic organisms Streptococcus milleri from purulent disease and abscesses.</p>
<p>Topical corticosteroids are classified according to their potency into mild, moderate, potent, and very potent categories. It is recognized that topical corticosteroid preparations can be absorbed through the skin and may result in suppression of hypothalamo-pituitary-adrenal (HPA) axis and may cause Cushing&#x2019;s syndrome. Prolonged steroid use is associated with myriad side effects. Androgen levels were on average increased compared with controls, but were normal in many individual patients. The application of topical corticosteroids on thin and damaged skin, on the elderly or paediatric population or under occlusion, intertriginous areas or moisture areas increases risk of side effects [<xref ref-type="bibr" rid="ref4">4</xref>].</p>
<p>Corticosteroids can cause virilization in females and feminization in males. And also corticosteroids may increase muscle mass as well as hypertrophy of the penis, accentuate scrotal folds and stimulate sebaceous glands in men.</p>
<p>Corticosteroids once absorbed stimulate sebocyte proliferation [<xref ref-type="bibr" rid="ref5">5</xref>] and aggravates sebaceous gland activity by its stimulatory effects on proliferation and differentiation in the presence of growth factors [<xref ref-type="bibr" rid="ref6">6</xref>]. Friction and pressure accentuate the inflammatory changes that invade the fat and cause further granulomatous change extending widely over the buttocks and thighs.</p>
<p>Following atypical sites already noted in dermatological literature, areola, infra- mammary and inter-mammary fold, [<xref ref-type="bibr" rid="ref7">7</xref>] abdomen, scalp, [<xref ref-type="bibr" rid="ref8">8</xref>] external auditory meatus, ear lobes, retro auricular fold [<xref ref-type="bibr" rid="ref9">9</xref>], abdomen and chest [<xref ref-type="bibr" rid="ref10">10</xref>].</p>
<p>In our case report patient continually applied ointment, which combines a potent topical steroid and an antifungal agent, twice daily to the intergluteal folds, pubic area and both groins. The occlusive nature of this anatomical location had led to an increase in the potency of the steroid.</p>
</sec>
<sec id="sec1-4" sec-type="conclusion">
<title>CONCLUSION</title>
<p>In conclusion, this is the first case of Hidradenitis Suppurativa due to topical corticosteroids. The clinicians should be aware of an unusual complication caused by topical corticosteroids.</p>
</sec>
</body>
<back>
<ack>
<title>ACKNOWLEDGEMENT</title>
<p>We gratefully acknowledge the help of the:</p>
<p>
<list list-type="order">
<list-item>
<p>Principal, PESIMSR, Kuppam.</p>
</list-item>
<list-item>
<p>The professor and head of the department of DVL, PESIMSR, Kuppam.</p>
</list-item>
</list>
</p>
</ack>
<ref-list>
<title>REFERENCES</title>
<ref id="ref1">
<label>1</label>
<nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Mukhopadhyay</surname>
<given-names>AK</given-names>
</name>
<name>
<surname>Baghel</surname>
<given-names>VA</given-names>
</name>
</person-group>
<article-title>study to evaluate the efficacy and safety of hydrocortisone aceponate 0.127&#x0025; lipophilic cream in steroid responsive dermatoses in Indian patients</article-title>
<source>Indian J Dermatol Venereol Leprol</source>
<year>2010</year>
<volume>76</volume>
<fpage>591</fpage>
</nlm-citation>
</ref>
<ref id="ref2">
<label>2</label>
<nlm-citation citation-type="book">
<person-group person-group-type="author">
<name>
<surname>Jones</surname>
<given-names>JB</given-names>
</name>
</person-group>
<person-group person-group-type="editor">
<name>
<surname>Rooks</surname>
<given-names>Burns T</given-names>
</name>
<name>
<surname>Breathnach</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Cox</surname>
<given-names>N</given-names>
</name>
<name>
<surname>Griffiths</surname>
<given-names>C</given-names>
</name>
</person-group>
<article-title>Topical Therapy</article-title>
<source>Rooks textbook of Dermatology</source>
<year>2010</year>
<volume>3</volume>
<edition>8th edition</edition>
<publisher-loc>Oxford</publisher-loc>
<publisher-name>Blackwell</publisher-name>
<fpage>73.16</fpage>
<lpage>22</lpage>
</nlm-citation>
</ref>
<ref id="ref3">
<label>3</label>
<nlm-citation citation-type="book">
<person-group person-group-type="author">
<name>
<surname>Hay</surname>
<given-names>RJ</given-names>
</name>
<name>
<surname>Adriaans</surname>
<given-names>BM</given-names>
</name>
</person-group>
<person-group person-group-type="editor">
<name>
<surname>Rooks</surname>
<given-names>Burns T</given-names>
</name>
<name>
<surname>Breathnach</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Cox</surname>
<given-names>N</given-names>
</name>
<name>
<surname>Griffiths</surname>
<given-names>C</given-names>
</name>
</person-group>
<article-title>Bacterial infections</article-title>
<source>Rooks textbook of Dermatology</source>
<year>2010</year>
<volume>3</volume>
<edition>8th edition</edition>
<issue>30</issue>
<publisher-loc>Oxford</publisher-loc>
<publisher-name>Blackwell</publisher-name>
<fpage>79</fpage>
<lpage>81</lpage>
</nlm-citation>
</ref>
<ref id="ref4">
<label>4</label>
<nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Pappas</surname>
<given-names>A</given-names>
</name>
</person-group>
<article-title>The relationship of diet and acne: A review</article-title>
<source>Dermatoendocrinol</source>
<year>2009</year>
<volume>1</volume>
<fpage>262</fpage>
<lpage>7</lpage>
</nlm-citation>
</ref>
<ref id="ref5">
<label>5</label>
<nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Feingold</surname>
<given-names>KR</given-names>
</name>
<name>
<surname>Elias</surname>
<given-names>PM</given-names>
</name>
</person-group>
<article-title>Endocrine-skin interactions. Cutaneous manifestations of adrenal disease, pheochromocytomas, carcinoid syndrome, sex hormone excess and deficiency, polyglandular autoimmune syndromes, multiple endocrine neoplasia syndromes, and other miscellaneous disorders</article-title>
<source>J Am Acad Dermatol</source>
<year>1988</year>
<volume>19</volume>
<fpage>1</fpage>
<lpage>20</lpage>
</nlm-citation>
</ref>
<ref id="ref6">
<label>6</label>
<nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Slokinski</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Wortman</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Luger</surname>
<given-names>T</given-names>
</name>
<name>
<surname>Paus</surname>
<given-names>R</given-names>
</name>
<name>
<surname>Solomon</surname>
<given-names>S</given-names>
</name>
</person-group>
<article-title>Corticotrophin releasing hormone and propiomelanocortin involvement in the cutaneous response to stress</article-title>
<source>Physiol Rev</source>
<year>2000</year>
<volume>80</volume>
<fpage>979</fpage>
<lpage>1020</lpage>
</nlm-citation>
</ref>
<ref id="ref7">
<label>7</label>
<nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Li</surname>
<given-names>EN</given-names>
</name>
<name>
<surname>Mofid</surname>
<given-names>MM</given-names>
</name>
<name>
<surname>Goldberg</surname>
<given-names>NH</given-names>
</name>
<name>
<surname>Silverman</surname>
<given-names>RP</given-names>
</name>
</person-group>
<article-title>Surgical management of hidradenitis suppurativa of the nipple-areolar complex</article-title>
<source>Ann Plast Surg</source>
<year>2004</year>
<volume>52</volume>
<fpage>220</fpage>
<lpage>3</lpage>
</nlm-citation>
</ref>
<ref id="ref8">
<label>8</label>
<nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Jain</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Sardana</surname>
<given-names>K</given-names>
</name>
<name>
<surname>Garg</surname>
<given-names>VK</given-names>
</name>
<name>
<surname>Sinha</surname>
<given-names>S</given-names>
</name>
</person-group>
<article-title>Hidradenitis suppurativa involving the preauricular region: An unusual location</article-title>
<source>Indian J Dermatol Venereol Leprol</source>
<year>2012</year>
<volume>78</volume>
<fpage>229</fpage>
</nlm-citation>
</ref>
<ref id="ref9">
<label>9</label>
<nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Moul</surname>
<given-names>DK</given-names>
</name>
<name>
<surname>Korman</surname>
<given-names>NJ</given-names>
</name>
</person-group>
<article-title>The cutting edge. Severe hidradenitis suppurativa treated with adalimumab</article-title>
<source>Arch Dermatol</source>
<year>2006</year>
<volume>142</volume>
<fpage>1110</fpage>
<lpage>2</lpage>
</nlm-citation>
</ref>
<ref id="ref10">
<label>10</label>
<nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Poitrine</surname>
<given-names>FC</given-names>
</name>
<name>
<surname>Revuz</surname>
<given-names>JE</given-names>
</name>
<name>
<surname>Wolkenstein</surname>
<given-names>P</given-names>
</name>
<name>
<surname>Viallette</surname>
<given-names>C</given-names>
</name>
<name>
<surname>Gabison</surname>
<given-names>G</given-names>
</name>
<name>
<surname>Pouget</surname>
<given-names>F</given-names>
</name>
<etal/>
</person-group>
<article-title>Clinical characteristics of a series of 302 French patients with hidradenitis suppurativa, with an analysis of factors associated with disease severity</article-title>
<source>J Am Acad Dermatol</source>
<year>2009</year>
<volume>61</volume>
<fpage>51</fpage>
<lpage>7</lpage>
</nlm-citation>
</ref>
</ref-list>
<fn-group>
<fn fn-type="supported-by">
<p><bold>Source of Support:</bold> Nil,</p>
</fn>
<fn fn-type="conflict">
<p><bold>Conflict of Interest:</bold> None declared.</p>
</fn>
</fn-group>
</back>
</article>
